Noncoding RNAs in regulation of cancer metabolic reprogramming

32Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Since the description of the Warburg effect 90 years ago, metabolic reprogramming has been gradually recognized as a major hallmark of cancer cells. Mounting evidence now indicates that cancer is a kind of metabolic disease, quite distinct from conventional perception. While metabolic alterations in cancer cells have been extensively observed in glucose, lipid, and amino acid metabolisms, its underlying regulatory mechanisms are still poorly understood. Noncoding RNA, also known as the “dark matter in life,” functions through various mechanisms at RNA level regulating different biological pathways. The last two decades have witnessed the booming of noncoding RNA study on microRNA (miRNA), long noncoding RNA (lncRNA), circular RNA (circRNA), PIWI-interacting RNA (piRNA), etc. In this chapter, we will discuss the regulatory roles of noncoding RNAs on cancer metabolism.

Cite

CITATION STYLE

APA

Yang, D., Sun, L., Li, Z., & Gao, P. (2016). Noncoding RNAs in regulation of cancer metabolic reprogramming. In Advances in Experimental Medicine and Biology (Vol. 927, pp. 191–215). Springer New York LLC. https://doi.org/10.1007/978-981-10-1498-7_7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free